SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Anita Williams, Michael Corkill, Management of Chronic Conditions in the Foot and Lower Leg, 2015,

    CrossRef

  2. 2
    Martin Wehling, Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects, European Journal of Clinical Pharmacology, 2014, 70, 10, 1159

    CrossRef

  3. 3
    Tsuyoshi Fujita, Hiromu Kutsumi, Tsuyoshi Sanuki, Takanobu Hayakumo, Takeshi Azuma, Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuries, Journal of Gastroenterology, 2013, 48, 5, 559

    CrossRef

  4. 4
    Rubén Casado-Arroyo, Carla Gargallo, Ángel Lanas Arbeloa, Balancing the risk and benefits of low-dose aspirin in clinical practice, Best Practice & Research Clinical Gastroenterology, 2012, 26, 2, 173

    CrossRef

  5. 5
    Nicola J. Gullick, David L. Scott, Co-morbidities in established rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2011, 25, 4, 469

    CrossRef

  6. 6
    Carlos Sostres, Angel Lanas, Epidemiology and Demographics of Upper Gastrointestinal Bleeding: Prevalence, Incidence, and Mortality, Gastrointestinal Endoscopy Clinics of North America, 2011, 21, 4, 567

    CrossRef

  7. 7
    Byung ho Lee, Byung-Joon Shin, Dong Jun Kim, Jae Chul Lee, Kyung Soo Suk, Ye-Soo Park, Ki-Won Kim, Kyu Jung Cho, Keun-young Shin, Min-suk Koh, Seong-Hwan Moon, Gastrointestinal Risk Assessment in the Patients Taking Nonsteroidal Anti-inflammarory Drugs for Lumbar Spinal Disease, Journal of Korean Society of Spine Surgery, 2011, 18, 4, 239

    CrossRef

  8. 8
    Paola Patrignani, Stefania Tacconelli, Annalisa Bruno, Carlos Sostres, Angel Lanas, Managing the adverse effects of nonsteroidal anti-inflammatory drugs, Expert Review of Clinical Pharmacology, 2011, 4, 5, 605

    CrossRef

  9. 9
    Elena Myasoedova, Nicholas J. Talley, Nisha J. Manek, Cynthia S. Crowson, Prevalence and Risk Factors of Gastrointestinal Disorders in Patients with Rheumatoid Arthritis: Results from a Population-Based Survey in Olmsted County, Minnesota, Gastroenterology Research and Practice, 2011, 2011, 1

    CrossRef

  10. 10
    Carlos Sostres, Carla J. Gargallo, Maria T. Arroyo, Angel Lanas, Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract, Best Practice & Research Clinical Gastroenterology, 2010, 24, 2, 121

    CrossRef

  11. 11
    Michael James, Susanna Proudman, Les Cleland, Fish oil and rheumatoid arthritis: past, present and future, Proceedings of the Nutrition Society, 2010, 69, 03, 316

    CrossRef

  12. 12
    Chris Metcalfe, Benedict W Wheeler, David Gunnell, Richard M Martin, International regulatory activity restricting COX-2 inhibitor use and deaths due to gastrointestinal haemorrhage and myocardial infarction, Pharmacoepidemiology and Drug Safety, 2010, 19, 8
  13. 13
    Leslie G. Cleland, Michael J. James, Susanna M. Proudman, Dietary fats and inflammation: The medicinal use of fish oil, Nutrition & Dietetics, 2009, 66, 1
  14. 14
    Marco Lazzaroni, Gabriele Bianchi Porro, Management of NSAID-Induced Gastrointestinal Toxicity, Drugs, 2009, 69, 1, 51

    CrossRef

  15. 15
    Majid Vakily, Weijiang Zhang, Jingtao Wu, Stuart N. Atkinson, Darcy Mulford, Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials*, Current Medical Research and Opinion, 2009, 25, 3, 627

    CrossRef

  16. 16
    Benedict W. Wheeler, Chris Metcalfe, David Gunnell, Peter Stephens, Richard M. Martin, Population impact of regulatory activity restricting prescribing of COX-2 inhibitors: ecological study, British Journal of Clinical Pharmacology, 2009, 68, 5
  17. 17
    S. E. Lester, S. M. Proudman, A. T. Y. Lee, C. A. Hall, L. McWilliams, M. J. James, L. G. Cleland, Treatment-induced stable, moderate reduction in blood cell counts correlate to disease control in early rheumatoid arthritis, Internal Medicine Journal, 2009, 39, 5
  18. 18
    Leslie R. Ballou, Benjamin W.E. Wang, Kelley's Textbook of Rheumatology, 2009,

    CrossRef

  19. 19
    Deepak L. Bhatt, James Scheiman, Neena S. Abraham, Elliott M. Antman, Francis K.L. Chan, Curt D. Furberg, David A. Johnson, Kenneth W. Mahaffey, Eamonn M. Quigley, Robert A. Harrington, Eric R. Bates, Charles R. Bridges, Mark J. Eisenberg, Victor A. Ferrari, Mark A. Hlatky, Sanjay Kaul, Jonathan R. Lindner, David J. Moliterno, Debabrata Mukherjee, Richard S. Schofield, Robert S. Rosenson, James H. Stein, Howard H. Weitz, Deborah J. Wesley, ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use, The American Journal of Gastroenterology, 2008, 103, 11, 2890

    CrossRef

  20. 20
    Deepak L. Bhatt, James Scheiman, Neena S. Abraham, Elliott M. Antman, Francis K.L. Chan, Curt D. Furberg, David A. Johnson, Kenneth W. Mahaffey, Eamonn M. Quigley, Robert A. Harrington, Eric R. Bates, Charles R. Bridges, Mark J. Eisenberg, Victor A. Ferrari, Mark A. Hlatky, Sanjay Kaul, Jonathan R. Lindner, David J. Moliterno, Debabrata Mukherjee, Richard S. Schofield, Robert S. Rosenson, James H. Stein, Howard H. Weitz, Deborah J. Wesley, ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use, Journal of the American College of Cardiology, 2008, 52, 18, 1502

    CrossRef

  21. 21
    Arthur L Weaver, Current and Emerging Treatments for Mild/Moderate Acute Ambulatory Pain, American Journal of Therapeutics, 2008, 15, Supplement 10, S12

    CrossRef

  22. 22
    Joseph Misdraji, Drug-induced pathology of the upper gastrointestinal tract, Diagnostic Histopathology, 2008, 14, 9, 411

    CrossRef

  23. 23
    Sjef van der Linden, Issues in the Treatment of Ankylosing Spondylitis with Non-Steroidal Anti-Inflammatory Drugs, Wiener Medizinische Wochenschrift, 2008, 158, 7-8, 195

    CrossRef

  24. 24
    M.T. Arroyo, S. Mostacero, L. Corts, Patolog?a gastroduodenal causada por antiinflamatorios no esteroideos, Medicine - Programa de Formaci?n M?dica Continuada Acreditado, 2008, 10, 2, 95

    CrossRef

  25. 25
    Estíbaliz Loza, Revisión sistemática: ¿es eficaz y seguro el uso de AINE para los ancianos?, Reumatología Clínica, 2008, 4, 5, 172

    CrossRef

  26. 26
    Estíbaliz Loza, Systematic Review: Is the Use of NSAIDs Effective and Safe in the Elderly?, Reumatología Clínica (English Edition), 2008, 4, 5, 172

    CrossRef

  27. 27
    U. Kiltz, J. Zochling, W. E. Schmidt, J. Braun, Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?, Rheumatology, 2008, 47, 9, 1342

    CrossRef

  28. 28
    Elham Rahme, Alan N. Barkun, Youssef Toubouti, Alissa Scalera, Sophie Rochon, Jacques Lelorier, Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?, Arthritis Care & Research, 2007, 57, 5
  29. 29
    Helena T.J.I. De Leest, Kirsti S.S. Steen, Willem F. Lems, Johannes W.J. Bijlsma, Mart A.F.J. Van De Laar, A. Margriet Huisman, Harald E. Vonkeman, Harry H.M.L. Houben, Sylvana W. Kadir, Piet J. Kostense, Maurits W. Van Tulder, Ernst J. Kuipers, Maarten Boers, Ben A.C. Dijkmans, Eradication of Helicobacter pylori Does Not Reduce the Incidence of Gastroduodenal Ulcers in Patients on Long-term NSAID Treatment: Double-Blind, Randomized, Placebo-Controlled Trial, Helicobacter, 2007, 12, 5
  30. 30
    E. RAHME, H. NEDJAR, A. BIZZI, S. MORIN, Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study, Alimentary Pharmacology & Therapeutics, 2007, 26, 10
  31. 31
    Susanna M. Proudman, Helen I. Keen, Lisa K. Stamp, Anita T.Y. Lee, Fiona Goldblatt, Oliver C. Ayres, Maureen Rischmueller, Michael J. James, Catherine L. Hill, Gillian E. Caughey, Leslie G. Cleland, Response-Driven Combination Therapy with Conventional Disease-Modifying Antirheumatic Drugs Can Achieve High Response Rates in Early Rheumatoid Arthritis with Minimal Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Use, Seminars in Arthritis and Rheumatism, 2007, 37, 2, 99

    CrossRef

  32. 32
    M. J. James, R. J. Cook-Johnson, L. G. Cleland, Selective COX-2 Inhibitors, Eicosanoid Synthesis and Clinical Outcomes: A Case Study of System Failure, Lipids, 2007, 42, 9, 779

    CrossRef

  33. 33
    David Henry, Patricia McGettigan, Selective COX-2 Inhibitors: A Promise Unfulfilled?, Gastroenterology, 2007, 132, 2, 790

    CrossRef

  34. 34
    Leslie Cleland, Lisa Stamp, Optimizing Women's Health through Nutrition, 2007,

    CrossRef

  35. 35
    Nurullah Akkoc, Sjef van der Linden, Muhammad Asim Khan, Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy, Best Practice & Research Clinical Rheumatology, 2006, 20, 3, 539

    CrossRef

  36. 36
    P. N. POST, E. J. KUIPERS, G. A. MEIJER, Declining incidence of peptic ulcer but not of its complications: a nation-wide study in The Netherlands, Alimentary Pharmacology & Therapeutics, 2006, 23, 11
  37. 37
    Rajaa Lagnaoui, Marie Baumevielle, Bernard Bégaud, Pierre Pouyanne, Gwenaëlle Maurice, Fanny Depont, Nicholas Moore, Less Use of NSAIDs in Long-Term than in Recent Chondroitin Sulphate Users in Osteoarthritis: a Pharmacy-based Observational Study in France, Thérapie, 2006, 61, 4, 341

    CrossRef

  38. 38
    Angel LANAS, Angel FERRANDEZ, NSAID-induced gastrointestinal damage: Current clinical management and recommendations for prevention, Chinese Journal of Digestive Diseases, 2006, 7, 3
  39. 39
    Theresa I. Shireman, Sally K. Rigler, Predictors of the selection of coxibs over nonselective NSAIDs in an older medicaid cohort, The American Journal of Geriatric Pharmacotherapy, 2006, 4, 3, 210

    CrossRef

  40. 40
    Jean Sibilia, Gilbert Deray, Gilles Montalescot, Que connaît-on de la toxicité cardiovasculaire des AINS?, La Presse Médicale, 2006, 35, 11

    CrossRef

  41. 41
    C. SCARPIGNATO, I. PELOSINI, Review article: the opportunities and benefits of extended acid suppression, Alimentary Pharmacology & Therapeutics, 2006, 23,
  42. 42
    Eliza F Chakravarty, James F Fries, Science as experiment; science as observation, Nature Clinical Practice Rheumatology, 2006, 2, 6, 286

    CrossRef

  43. 43
    James M Scheiman, Unmet Needs in Non-steroidal Anti-inflammatory Drug-induced Upper Gastrointestinal Diseases, Drugs, 2006, 66, Suppl 1, 15???21

    CrossRef

  44. 44
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2005, 14, 2
  45. 45
    Mansoor Ahmed, Dinesh Khanna, Daniel E Furst, Meloxicam in rheumatoid arthritis, Expert Opinion on Drug Metabolism & Toxicology, 2005, 1, 4, 739

    CrossRef

  46. 46
    Byron Cryer, NSAID-Associated Deaths: The Rise and Fall of NSAID-Associated GI Mortality, The American Journal of Gastroenterology, 2005, 100, 8, 1694

    CrossRef

  47. 47
    A. L. WEAVER, Review article: aspirin, non-steroidal anti-inflammatory drugs and cyclo-oxygenase-1 sparing agents, Alimentary Pharmacology & Therapeutics Symposium Series, 2005, 1, 1
  48. 48
    R. H. HUNT, Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005, Alimentary Pharmacology & Therapeutics, 2005, 22,
  49. 49
    Daniel H. Solomon, Selective cyclooxygenase 2 inhibitors and cardiovascular events, Arthritis & Rheumatism, 2005, 52, 7
  50. 50
    Angel Lanas Arbeloa, Carlos Sostres Homedes, Gastrointestinal Adverse Drug Reactions,